ConvaTec Group’s (CTEC) Buy Rating Reiterated at Deutsche Bank Aktiengesellschaft

ConvaTec Group (LON:CTEC)‘s stock had its “buy” rating reaffirmed by stock analysts at Deutsche Bank Aktiengesellschaft in a research report issued on Wednesday,Digital Look reports. They presently have a GBX 315 price objective on the stock. Deutsche Bank Aktiengesellschaft’s price target points to a potential upside of 39.13% from the stock’s previous close.

Other analysts have also recently issued reports about the company. UBS Group restated a “buy” rating and issued a GBX 375 target price on shares of ConvaTec Group in a report on Monday, May 18th. Jefferies Financial Group restated a “buy” rating and set a GBX 300 price target on shares of ConvaTec Group in a research report on Wednesday. JPMorgan Chase & Co. lowered their price objective on shares of ConvaTec Group from GBX 307 to GBX 294 and set an “overweight” rating for the company in a research note on Friday, May 22nd. Royal Bank Of Canada reiterated an “outperform” rating and issued a GBX 315 price objective on shares of ConvaTec Group in a research note on Monday. Finally, Peel Hunt reiterated an “add” rating and set a GBX 270 price target on shares of ConvaTec Group in a report on Tuesday. Eight equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of GBX 306.

ConvaTec Group Stock Performance

CTEC stock traded down GBX 3 during midday trading on Wednesday, hitting GBX 226.40. 1,839,836,250 shares of the stock traded hands, compared to its average volume of 53,635,801. The firm has a market cap of £4.42 billion, a P/E ratio of 26.33, a PEG ratio of 0.93 and a beta of 0.77. ConvaTec Group has a 1-year low of GBX 193 and a 1-year high of GBX 259.30. The stock’s fifty day simple moving average is GBX 211.76 and its 200-day simple moving average is GBX 221.09. The company has a debt-to-equity ratio of 99.96, a current ratio of 1.53 and a quick ratio of 0.96.

Insider Buying and Selling at ConvaTec Group

In other news, insider Jonny Mason bought 50,000 shares of ConvaTec Group stock in a transaction on Tuesday, May 26th. The shares were bought at an average cost of GBX 201 per share, for a total transaction of £100,500. 0.98% of the stock is currently owned by company insiders.

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.